This negative effect is mediated by the AT1R. Inhibition of Ang II action through an AT1 receptor blockade with specific antagonists or reduction of its production through angiotensin converting enzyme inhibitors results in improvement of glucose homeostasis both in animal models of insulin resistance and/or type 2 diabetes [1,2,3,4,5]. The gene discussed is AGTR1; the disease is Insulin resistance.